SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-022105
Filing Date
2019-04-30
Accepted
2019-04-30 07:24:17
Documents
4
Period of Report
2019-06-18
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv519539-def14a.htm DEF 14A 594501
2 GRAPHIC lg_fortress-biotech.jpg GRAPHIC 55834
3 GRAPHIC tv519539_pc1.jpg GRAPHIC 196721
4 GRAPHIC tv519539_pc2.jpg GRAPHIC 124450
  Complete submission text file 0001144204-19-022105.txt   1109289
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35366 | Film No.: 19778430
SIC: 2834 Pharmaceutical Preparations